ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

MITRA Mithra Pharmaceuticals SA

0,216
0,00 (0,00%)
21 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mithra Pharmaceuticals SA MITRA Euronext Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,00 0,00% 0,216 07:30:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,216
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
28/5/202415:41GLOBEMithra postpones its annual general meeting
03/5/202417:30GLOBEMithra enters into exclusive negotiations with Gedeon..
29/4/202407:00GLOBEMithra updates on offers received in the context of its..
22/4/202407:00GLOBEMithra secures court protection measures to advance..
08/3/202407:00GLOBEMithra reports full year 2023 financial results
05/3/202407:01GLOBEMithra announces changes to its executive management
05/3/202407:00GLOBEMithra initiates monetization process, receives bridge loan..
29/2/202411:42GLOBEDONESTA® safety study for menopause completes treatment..
15/2/202418:23GLOBEMithra sells shares in Mayne Pharma
06/2/202407:00GLOBEMithra updates on cash position
21/12/202317:45GLOBEMithra and Rafa Laboratories sign binding Head of Terms to..
20/12/202317:45GLOBEMithra Completes Pediatric Study of ESTELLE® in Adolescent..
18/12/202307:00GLOBEMithra Receives Positive DSMB Opinion on DONESTA® European..
04/12/202307:00GLOBEMithra and Gedeon Richter sign binding Head of Terms to..
30/11/202307:00GLOBEMithra receives guidance from the FDA for the DONESTA® NDA..
28/11/202317:45GLOBEMithra to hold five presentations on key role of estrogens..
07/11/202307:00GLOBEMithra’s NEXTSTELLIS® granted additional patent in the..
06/11/202318:52GLOBEMithra releases invitation to its extraordinary securities..
26/10/202307:00GLOBEMithra and Searchlight Pharma sign DONESTA® licensing..
23/10/202307:00GLOBEMithra to receive EUR 2.5 million milestone payment from..
17/10/202307:00GLOBEMithra’s Board of Directors to propose the removal of its..
11/10/202307:15GLOBEShareholder Letter
11/10/202307:00GLOBEMithra announces update to the agenda of its upcoming..
10/10/202318:00GLOBEMithra to Hold Presentations on Key Role of Estrogens in..
05/10/202307:00GLOBEMithra Provides an Update in the Context of Recent Market..
27/9/202307:00GLOBEMithra Announces Presentation of Positive Data on Estetrol..
26/9/202307:00GLOBEMithra Financial Results for First-Half 2023
22/9/202313:30GLOBEMithra présentera ses résultats financiers du premier..
21/9/202317:55GLOBEMithra to Hold Investor Call on H1 2023 Financial Results on..
12/9/202317:45GLOBEPublication of a Transparency Notification Received from..
11/9/202307:30GLOBELetter to Shareholders and Corporate Update
28/8/202317:45GLOBEMithra completes EUR 20 million private placement in equity..
24/8/202307:33GLOBEMithra prices private placement to raise EUR 20 million in..
08/8/202307:30GLOBEMithra and Gedeon Richter Sign Supply Agreement for..
03/8/202307:30GLOBEMithra Receives EUR 1.25 Million Milestone Payment from Fuji..
31/7/202307:30GLOBEMithra and Searchlight Pharma Announce Donesta® Licensing..
17/7/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's..
04/7/202317:45GLOBENotice of Adjustment of the Conversion Price of Mithra's EUR..
26/6/202317:45GLOBEMithra Announces Information on the Total Number of Voting..

Dernières Valeurs Consultées

Delayed Upgrade Clock